Arkolith/Insider Trading/CRBU/Form 4

Ryali Sriram

Chief Financial OfficerCaribou Biosciences, Inc. (CRBU) · full profile →Form 4 · filed Jan 30, 2025
Net Buying
Open-Market Buys
$25K
Open-Market Sells
$0
Net Open-Market Flow
$25K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 29, 2025Buy(P)17K$1.42$25K17K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001762893-25-000009) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML